Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Non Operating Income: 2015-2025

Historic Non Operating Income for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to $385,023.

  • AC Immune's Non Operating Income rose 118.89% to $385,023 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 163.48%. This contributed to the annual value of $1.7 million for FY2024, which is 347.65% up from last year.
  • AC Immune's Non Operating Income amounted to $385,023 in Q3 2025, which was up 117.70% from -$2.2 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Non Operating Income ranged from a high of $4.8 million in Q3 2021 and a low of -$2.2 million during Q2 2025.
  • Moreover, its 3-year median value for Non Operating Income was $240,230 (2023), whereas its average is -$33,413.
  • Its Non Operating Income has fluctuated over the past 5 years, first spiked by 4,341.04% in 2021, then plummeted by 2,510.89% in 2023.
  • Over the past 5 years, AC Immune's Non Operating Income (Quarterly) stood at $1.6 million in 2021, then plummeted by 103.16% to -$51,901 in 2022, then plummeted by 2,510.89% to -$1.4 million in 2023, then surged by 337.89% to $3.2 million in 2024, then surged by 118.89% to $385,023 in 2025.
  • Its Non Operating Income was $385,023 in Q3 2025, compared to -$2.2 million in Q2 2025 and $379,277 in Q1 2025.